M. Coppola

Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia

S. Perrotta, M. Lidonnici, S. Galimberti, 2019, Nature Medicine.

Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature.

A. Sica, S. Guastafierro, M. Ferrara, 2009, Leukemia research.

Occult HBV infection in the oncohematological setting

E. Sagnelli, C. Sagnelli, R. Zampino, 2016, Infection.

Gene Therapy for Beta Thalassemia: Preliminary Results from the PHASE I/II Tiget-Bthal Trial of Autologous Hematopoietic Stem Cells Genetically Modified with GLOBE Lentiviral Vector

S. Perrotta, M. Lidonnici, L. Naldini, 2017 .

Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia

S. Perrotta, M. Lidonnici, S. Galimberti, 2019, Nature Medicine.

Plerixafor on demand in ten healthy family donors as a rescue strategy to achieve an adequate graft for stem cell transplantation

F. Ciceri, R. Milani, A. Assanelli, 2015, Transfusion.